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The present special issue is an attempt to explore some of
the diverse aspects of copper involvement in the physiology
ofthebrain.Thecontributionsexamineveryhottopics,such
astherelationshipbetweencopperandsynaptictransmission
or copper involvement in Alzheimer’s disease (AD) and even
include a computational model of copper binding to the
amyloid precursor protein (S. Azini and R. Rouk 2011).
In this model, the authors applied theoretical methods of
computational chemistry to determine structure, binding af-
ﬁnities, and reduction potentials of Cu(II) and Cu(I) bound
to models of the Asp1, Ala2, His6, and His13His14 regions of
the amyloid beta peptide.
A bulk of new studies has been recently published on the
roleofcopperinthebiologicalprocessessubtendingsynaptic
transmission, and three contributions on this subject are
included in the special issue. Speciﬁcally, one contribution
describes a study in a cellular model of oocytes, which inves-
tigated the connection between copper and the prion protein
in neurotransmission mediated by ATP-evoked currents (R.
A. Lorca et al., 2011). A study on mouse hippocampal slices
investigates copper inhibition of glutamatergic NMDA re-
ceptor-independent long-term potentiation (N. L. Salazar-
Weber and J. P. Smith 2011), and a human model explores
the eﬀects of systemic copper on glutamatergic mediated
excitability in the primary somatosensory cortex (F. Tecchio
et al., 2011).
Since the original papers that have been fuelling a heated
debate in the literature about the pros and cons of copper
on cognition are rather scattered and discordant, the aim
of the editors was to select contributions that all together
would provide the reader with an adequate overview of the
issue but would still leave the reader free to form personal
and hopefully critical opinions. In this section, some of
the papers give a good overview of the nonunivocal in
vitro, animal and human ﬁndings which demonstrate the
involvement of copper in AD (D. Kaden et al. 2011). Also,
in their paper, Y. Manso and colleagues (Y. Manso et al.,
2011) review the preclinical and clinical literature dedicated
to therapeutic interventions aimed at delaying or possibly
revertingADprogressionviathemodulationofbraincopper
levels (Y. Manso et al., 2011). In the same section, some
reports are preliminary but still original in their content,
as, for example, the paper dealing with the inﬂuence of
water quality on the cholesterol-fed rabbit model, which
suggests that the origin of the brain neuroﬁbrillary tangles
is possibly systemic and somehow related to disturbances
to the blood brain barrier mediated by copper ingested
through the diet (D. L. Sparks et al., 2011), as well as the2 International Journal of Alzheimer’s Disease
study by S. Bucossi and coworkers (S. Bucossi et al., 2011)
whichdemonstratesanassociationbetweensinglenucleotide
polymorphisms of the Wilson’s disease gene and AD. T. U.
Hoogenraad discusses further the link between these two
neurologicaldisorders(T.U.Hoogenraad2011),whichshare
the presence of abnormalities in toxic nonceruloplasmin
(alsonamed“free”)copper,proposingZinctherapyasavalid
tool against AD, as it has already proven to be in Wilson’s
disease. The perspective that comes out of his contribution
(T. U. Hoogenraad 2011), for some maybe visionary or
prophetic, is probably somehow adherent to the author’s
attitude, pragmatic, as can be expected from a physician who
has dedicated his career to Wilson’s disease clinical care, but
also ﬁlled with enthusiasm, as demonstrated by his attitude
to be prone to ideas of shifting paradigms: he was one of the
pioneer of Zinc therapy in Wilson’s disease.
With a totally diﬀerent approach, G. J. Brewer (G. J.
Brewer 2011) discusses AD from an epidemiologic point of
view, advancing the hypothesis that ingestion of inorganic
copper from copper-made plumbing or via consumption
of copper-rich dietary supplements may have a role in AD
generation. Finally, the issue presents also a study connecting
higher levels of copper to gender diﬀerences and cognitive
status (J. F. Quinn et al., 2011).
In conclusion, is copper good or bad in general for
human health and in particular for cognition? Of course, the
questionisfarfrombeingansweredinthisspecialissue,butit
is well discussed. These editors recommend reading carefully
the diverse interpretations presented but also going back and
read the original works which are at the basis of them. In
fact, even though reliable, review articles often decrease the
critical attitude of the reader, as recent publications about
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